Skip to main content

Advertisement

Log in

Effect of Colpexin Sphere on pelvic floor muscle strength and quality of life in women with pelvic organ prolapse stage I/II: a randomized controlled trial

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Colpexin Sphere was effective for advanced pelvic organ prolapse. The aim of this study was to assess the effect of Colpexin Sphere in women with pelvic organ prolapse (POP) stage I or II on pelvic floor muscle strength, quality of life, and POP stage.

Methods

Women were randomly divided into Colpexin Sphere with pelvic floor muscle exercise group and exercise only group for a 16-week period. They had Colpexin pull test and digital test every 4 weeks. Quality of life and POP stage were re-evaluated at the end of treatment.

Results

Ninety-one women were recruited and 85 completed. Colpexin Sphere plus pelvic floor exercise improved pelvic floor muscle strength. There was no significant difference between both groups. Vaginal symptom score decreased in both groups while the stages of prolapse did not change.

Conclusions

Colpexin Sphere plus pelvic floor exercise and exercise alone improved pelvic floor muscle strength.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Guerette N, Neimark M, Kopka SL, Jones JE, Davila GW (2004) Initial experience with a new method for the dynamic assessment of pelvic floor function in women; the Kolpexin Pull Test. Int Urogynecol J 15:39–43

    Article  Google Scholar 

  2. Lukban JC, Aguirre OA, Davila GW, Sand PK (2006) Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse. Int Urogynecol J 17:449–454

    Article  Google Scholar 

  3. Brakken IH, Majida M, Engh ME, Bo K (2010) Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol 203:170, e1-7

    Google Scholar 

  4. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17

    Article  PubMed  CAS  Google Scholar 

  5. Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C et al (2005) Standardization of termination of pelvic floor muscle function and dysfunction: Report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn 24:374–380

    Article  PubMed  Google Scholar 

  6. Jean-Michel M, Biller DH, Bena JF, Davila W (2010) Measurement of pelvic floor muscular strength with the Colpexin pull test: A comparative study. Int Urogynecol J 21:1011–1017

    Article  PubMed  Google Scholar 

  7. Brink CA, Sampselle CM, Wells TJ, Diokno AC, Gillis GL (1989) A digital test for pelvic muscle strength in older women with urinary incontinence. Nurs Res 38:196–199

    Article  PubMed  CAS  Google Scholar 

  8. Harnsomboon T, Manonai J, Sarit-aprak S, Wattanayingcharoenchai R, Chittacharoen A, Suthutvoravut (2010) Effect of colpexin sphere on pelvic floor muscle strength in women with pelvic organ prolapse: A randomized controlled trial (a preliminary report). Arch Gynecol Obstet 283:575–579

    Article  PubMed  Google Scholar 

  9. Price N, Jackson SR, Avery K, Brookes ST, Abrams P (2006) Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: ICIQ-VS. BJOG 113:700–712

    Article  PubMed  CAS  Google Scholar 

  10. Chen L, Ashton-Miller JA, Hsu Y, DeLancey JO (2006) Interaction among apical support, levator ani impairment, and anterior vaginal wall prolapse. Obstet Gynecol 108:324–332

    Article  PubMed  Google Scholar 

  11. Hove MS, Pool-Goudzwaard A, Eijkemans M, Steegers-Theunissen R, Burger C, Vierhout M (2010) Pelvic floor muscle function in a general population of women with and without pelvic organ prolapse. Int Urogynecol J 21:311–319

    Article  Google Scholar 

  12. Hagen S, Stark D, Maher C, Adams E (2006) Conservative management of pelvic organ prolapse in women. Cochrane Database Syst Rev 4:CD003882

    PubMed  Google Scholar 

  13. Hagen S, Stark D, Glazener C, Sinclair L, Ramsay I (2009) A randomized controlled trial of pelvic floor muscle training for stage I and II pelvic organ prolapse. Int Urogyecol J Pelvic Floor Dysfunct 20:45–51

    Article  Google Scholar 

  14. Braekken IH, Majida M, Engh ME, Bo K (2010) Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: A randomized controlled trial. Obstet Gynecol 115:317–324

    Article  PubMed  Google Scholar 

  15. Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF (1999) Signs of genital prolapse in a Swedish population of women 20–59 years of age and possible related factors. Am J Obstet Gynecol 180:299–305

    Article  PubMed  CAS  Google Scholar 

  16. Phillips CH, Anthony F, Benyon C, Monga AK (2006) Collagen metabolism in the uterosacral ligaments and vaginal skin of women with uterine prolapse. BJOG 113:39–46

    PubMed  CAS  Google Scholar 

  17. Mouritsen L (2005) Classification and evaluation of prolapse. Best Pract Res Clin Obstet Gynaecol 19:895–911

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jittima Manonai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manonai, J., Harnsomboon, T., Sarit-apirak, S. et al. Effect of Colpexin Sphere on pelvic floor muscle strength and quality of life in women with pelvic organ prolapse stage I/II: a randomized controlled trial. Int Urogynecol J 23, 307–312 (2012). https://doi.org/10.1007/s00192-011-1569-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-011-1569-y

Keywords

Navigation